- ABOUT US
President and Chief Executive Officer
Richard Hamilton has been the chief executive and a board member of Ceres since 2002. The prior four years he served as the company's Chief Financial Officer. In addition to his leadership role at Ceres, he sits on the Keck Graduate Institute Advisory Council and serves as a board member of First Green Partners. He was a founding member of the Council for Sustainable Biomass Production. Mr. Hamilton has previously served on the U.S. Dept. of Energy's Biomass R&D Technical Advisory Committee and has been active in the Biotechnology Industry Organization (BIO), where he has served as Vice Chairman of the organization, chaired its Food and Agriculture Governing Board and served in other leadership roles. Mr. Hamilton frequently speaks before policymakers, business leaders and scientific organizations regarding biotechnology, biofuels and energy crops. He has addressed the House Agriculture Committee, the President's Council of Advisors on Science and Technology and the National Academy of Sciences, among others. Earlier in his career, Mr. Hamilton was a principal at Oxford Bioscience Partners, one of the leading investors in the genomics field and a founder of Ceres. From 1990 to 1991 he was a Howard Hughes Medical Institute Research Fellow at Harvard Medical School. Mr. Hamilton holds a Ph.D. in Molecular Biology from Vanderbilt University.
Paul M. Kuc
Chief Financial Officer
Paul Kuc joined Ceres in 2008 as Chief Financial Officer, following a 12-year career with Monsanto, where he held various regional and global finance positions, including posts in Argentina, Brazil, Canada, Mexico and the United States. At Monsanto, among other responsibilities, Mr. Kuc developed and implemented international costing and financial systems for the seed and agricultural biotechnology company. He began his career at pharmaceutical company Eli Lilly. Mr. Kuc holds a Master’s of Science degree in Economics from the University of Lodz, Poland and an MBA from the Ivey Business School, University of Western Ontario, Canada.
Wilfriede van Assche
Senior Vice President & General Counsel; Secretary
Wilfriede van Assche joined Ceres in 2000. She has more than 20 years of legal experience, primarily in the plant biotechnology industry. Until 2000, Ms. van Assche was the General Counsel of the plant biotechnology and seed divisions of Aventis, a leading life sciences company that is now part of Bayer AG. Previously, she was the General Counsel at Plant Genetic Systems N.V. Ms. van Assche holds law degrees from the University of Leuven and the College of Europe. She is a member of the State Bar of California.
Vice President of Product Development
As Vice President of Product Development, Walter Nelson oversees the management of the company's product portfolio, including the advancement of seed and trait products. He also leads several of Ceres' external collaboration teams and manages various licensing and intellectual propriety activities. Prior to his current position, Mr. Nelson managed several of Ceres' product lines, and led a number of the Ceres' early trait screening and discovery projects. He has 18 years of experience in the biotechnology and seed industries and holds an MBA and an undergraduate degree in biochemistry from the University of California at Los Angeles.
Vice President of Trait Development
Roger Pennell joined Ceres in 1998 and held various research management positions until 2009 when he assumed his current role as Vice President of Trait Development. Dr. Pennell is an Adjunct Professor in the Department of Molecular, Cellular and Developmental Biology at the University of California, Los Angeles and a frequent reviewer for the scientific press. Dr. Pennell holds a Ph.D. from University College London. He performed post-doctoral research at the John Innes Institute and Wageningen Agricultural University, and in 1990 was the recipient of a prestigious Royal Society University Research Fellowship, which he used at University College London and, from 1995, at the Salk Institute. During this time, Dr. Pennell studied cellular and molecular aspects of plant growth, development and disease resistance, and has published more than 40 scientific papers on these subjects.
Vice President of Genomic Technologies
Tim Swaller directs Ceres’ information technology, computational biology and genomic efforts, including the commercial deployment of the company’s next-generation genome visualization software known as Persephone™. During his 15-year tenure with the company, he has helped build an integrated R&D platform consisting of genomics technologies, field and laboratory data management software and systems, informatics, and high-throughput laboratory pipelines. Most recently he has applied Ceres’ molecular genetics and informatics capabilities toward new discovery efforts, such as quantitative genetic analyses and genome-wide association studies to drive Ceres’ marker-assisted plant breeding programs. Prior to joining Ceres, he was a researcher at the Washington University Genome Sequencing Center in St. Louis, Missouri working on human and mouse genome sequencing. Swaller holds an MBA from the Anderson School of Management at the University of California at Los Angeles (UCLA).
General Manager, Ceres Sementes do Brasil
André Franco oined Ceres as general manager of our Brazilian subsidiary in 2013. Prior to joining Ceres, Franco held a number of leadership roles during his 21-year tenure at Monsanto Brasil, including sales and marketing, distribution, human resources, product licensing and biotech trait introductions. He holds an MBA from Fundação Dom Cabral and Executive Development Program from Kellogg School of Management at Northwestern University. He received his undergraduate in Agronomic Engineering from the University of São Paulo.